BioNTech COVID-19 (BNT162b2) Vaccination and Varicella Zoster Reactivation: A Comprehensive Cross-sectional Study
In conclusion, COVID-19 vaccination was not found to be associated with an increased risk of HZ-related admission and complications.PMID:38348725 | DOI:10.2340/actadv.v104.18389 (Source: Acta Dermato-Venereologica)
Source: Acta Dermato-Venereologica - February 13, 2024 Category: Dermatology Authors: Shir Azrielant Yair Levin Alon Peled Liat Samuelov Eli Sprecher Mor Pavlovsky Source Type: research
BioNTech COVID-19 (BNT162b2) Vaccination and Varicella Zoster Reactivation: A Comprehensive Cross-sectional Study
In conclusion, COVID-19 vaccination was not found to be associated with an increased risk of HZ-related admission and complications.PMID:38348725 | DOI:10.2340/actadv.v104.18389 (Source: Acta Derm Venereol A...)
Source: Acta Derm Venereol A... - February 13, 2024 Category: Dermatology Authors: Shir Azrielant Yair Levin Alon Peled Liat Samuelov Eli Sprecher Mor Pavlovsky Source Type: research
Mesenchymal stromal cells (MSCs) as a therapeutic agent of inflammatory disease and infectious COVID-19 virus: live or dead mesenchymal?
Mol Biol Rep. 2024 Feb 10;51(1):295. doi: 10.1007/s11033-023-09174-x.ABSTRACTThe COVID-19 infection is a worldwide disease that causes numerous immune-inflammatory disorders, tissue damage, and lung dysfunction. COVID-19 vaccines, including those from Pfizer, AstraZeneca, and Sinopharm, are available globally as effective interventions for combating the disease. The severity of COVID-19 can be most effectively reduced by mesenchymal stromal cells (MSCs) because they possess anti-inflammatory activity and can reverse lung dysfunction. MSCs can be harvested from various sources, such as adipose tissue, bone marrow, periphera...
Source: Molecular Biology Reports - February 10, 2024 Category: Molecular Biology Authors: Ramiar Kamal Kheder Omeed Darweesh Bashdar Mahmud Hussen Snur Rasool Abdullah Abbas Basiri Mohammad Taheri Source Type: research
Mesenchymal stromal cells (MSCs) as a therapeutic agent of inflammatory disease and infectious COVID-19 virus: live or dead mesenchymal?
Mol Biol Rep. 2024 Feb 10;51(1):295. doi: 10.1007/s11033-023-09174-x.ABSTRACTThe COVID-19 infection is a worldwide disease that causes numerous immune-inflammatory disorders, tissue damage, and lung dysfunction. COVID-19 vaccines, including those from Pfizer, AstraZeneca, and Sinopharm, are available globally as effective interventions for combating the disease. The severity of COVID-19 can be most effectively reduced by mesenchymal stromal cells (MSCs) because they possess anti-inflammatory activity and can reverse lung dysfunction. MSCs can be harvested from various sources, such as adipose tissue, bone marrow, periphera...
Source: Mol Biol Cell - February 10, 2024 Category: Molecular Biology Authors: Ramiar Kamal Kheder Omeed Darweesh Bashdar Mahmud Hussen Snur Rasool Abdullah Abbas Basiri Mohammad Taheri Source Type: research
Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series
CONCLUSION: Cases of SLE associated with COVID-19 vaccination against are infrequent. However, clinical monitoring is recommended for persons receiving the SARS-CoV-2 vaccine, mainly those receiving the first dose and the Pfizer-BioNTech-162b2 vaccine.PMID:38315894 | DOI:10.1177/09612033241232054 (Source: Lupus)
Source: Lupus - February 5, 2024 Category: Rheumatology Authors: Nelson Luis Cahuapaza-Gutierrez Source Type: research
Relapse of minimal change disease following the third mRNA COVID-19 vaccination: a case report and literature review
AbstractMass vaccination is the most important strategy to terminate the coronavirus disease 2019 (COVID-19) pandemic. Reports suggest the potential risk of the development of new-onset or relapse of minimal change disease (MCD) following COVID-19 vaccination; however, details on vaccine-associated MCD remain unclear. A 43-year-old man with MCD, who had been in remission for 29 years, developed nephrotic syndrome 4 days after receiving the third dose of the Pfizer-BioNTech vaccine. His kidney biopsy revealed relapsing MCD. Intravenous methylprednisolone pulse therapy followed by oral prednisolone therapy was administere...
Source: CEN Case Reports - February 1, 2024 Category: Urology & Nephrology Source Type: research
Bilateral central retinal vein occlusion following COVID-19 vaccination: Cause or coincidence?
CONCLUSION: To our knowledge, we report the first case of bilateral CRVO in a healthy patient after anti-COVID 19 vaccination. CRVO occurred few days following third shot of vaccine followed by a sequential CRVO in the fellow eye in a patient with recently diagnosed very mild hypertension and no thrombo-embolic risk factors, strongly suggesting a relationship between both events. Nowadays, CRVO should be kept in mind as a potential side effect of Covid-19 vaccination and should be added to the spectrum of their ophthalmic complications.PMID:38291623 | DOI:10.1177/11206721241229109 (Source: European Journal of Ophthalmology)
Source: European Journal of Ophthalmology - January 31, 2024 Category: Opthalmology Authors: Khaled El Matri Slim Werda Zouheir Chebbi Rahma Saidane Meryem Doukh Racem Choura Yousra Falfoul Rim Limaiem Leila El Matri Source Type: research
Electronic Cigarettes for Smoking Cessation —A Clinician’s Dilemma
The randomized clinical trial by Lin et al in this issue of JAMA Internal Medicine demonstrated that participants randomized to nicotine electronic cigarettes (ECs) experienced greater sustained smoking abstinence at 6 months than participants randomized to medicinal nicotine gum and similar (noninferior) sustained abstinence to participants randomized to varenicline (Chantix; Pfizer), a partial nicotinic receptor agonist. Notably, the study, conducted in China with 1068 participants, compared only a single form of nicotine replacement therapy (NRT) rather than 2 NRT forms in combination (eg, patch plus gum or lozenge), wh...
Source: JAMA Internal Medicine - January 29, 2024 Category: Internal Medicine Source Type: research
Antibody Response after a Booster COVID-19 Vaccine Mixing in Vietnam
CONCLUSIONS: We found that the matching two doses of mRNA vaccines are more immunogenic as compared to the DNA vector vaccines. Furthermore, mixing AstraZeneca-Pfizer has higher antibody quantities as compared to matching vaccines, while lower the rate of advert events.PMID:38273758 | DOI:10.24976/Discov.Med.202436180.17 (Source: Discovery Medicine)
Source: Discovery Medicine - January 26, 2024 Category: Research Authors: Tram Hong Tran Hung Van Pham Thien Huu Doan Bach Kim Nguyen Toi Lam Phung Thai Duy Nguyen Source Type: research
